These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9142736)

  • 1. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours.
    Wafelman AR; Hoefnagel CA; Maessen HJ; Maes RA; Beijnen JH
    Eur J Nucl Med; 1997 May; 24(5):544-52. PubMed ID: 9142736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.
    Wafelman AR; Nortier YL; Rosing H; Maessen HJ; Taal BG; Hoefnagel CA; Maes RA; Beijnen JH
    Nucl Med Commun; 1995 Sep; 16(9):767-72. PubMed ID: 7478409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
    Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
    J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiochemical stability during infusion of 131I-labelled metaiodobenzylguanidine for therapeutic use.
    Wafelman AR; Hoefnagel CA; Beijnen JH
    Nucl Med Commun; 1993 Sep; 14(9):819-22. PubMed ID: 8233249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiochemical purity of iodine-131 labelled metaiodobenzylguanidine infusion fluids: a report from clinical practice.
    Wafelman AR; Suchi R; Hoefnagel CA; Beijnen JH
    Eur J Nucl Med; 1993 Jul; 20(7):614-6. PubMed ID: 8370383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
    Zagar I; Han R; Mitrovic S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
    Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
    Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I-MIBG therapy of neural crest tumours (review).
    Troncone L; Rufini V
    Anticancer Res; 1997; 17(3B):1823-31. PubMed ID: 9179240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient dosimetry after 131I-MIBG therapy for neuroblastoma and carcinoid tumours.
    Monsieurs MA; Thierens HM; Vral A; Brans B; De Ridder L; Dierckx RA
    Nucl Med Commun; 2001 Apr; 22(4):367-74. PubMed ID: 11338046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-MIBG scintigraphy in neural crest tumours.
    Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
    Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal iodine-131-meta-iodobenzylguanidine activity.
    Geatti O; Shapiro B; Shulkin B; Hutchinson R; Sisson JC
    Am J Physiol Imaging; 1988; 3(4):188-91. PubMed ID: 3214594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.
    Munkner T
    Semin Nucl Med; 1985 Apr; 15(2):154-60. PubMed ID: 4001964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
    Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
    Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
    Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
    Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of 131I-metaiodobenzylguanidine scintigraphy in the diagnosis of intestinal carcinoids].
    Bihl H; Sautter-Bihl ML; Wilhelm KR; Kimmig B
    Nuklearmedizin; 1987 Dec; 26(6):263-7. PubMed ID: 3438170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the uptake of 131I-radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma.
    O'Donoghue JA; Wheldon TE; Babich JW; Moyes JS; Barrett A; Meller ST
    Br J Radiol; 1991 May; 64(761):428-34. PubMed ID: 2036567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.